Metformin use in pregnancy: What about long‐term effects in offspring?
Abstract Metformin use in pregnancy is increasing worldwide. Unlike insulin, metformin crosses the placenta. Consequently, maternal and fetal concentrations are comparable. Teratogenic effects are not reported, nor are adverse pregnancy outcomes. Reduced risk of hypertensive disorders, hypoglycemia,...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2024-07-01
|
| Edice: | Acta Obstetricia et Gynecologica Scandinavica |
| Témata: | |
| On-line přístup: | https://doi.org/10.1111/aogs.14878 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|